Circulating growth-regulated oncogene α contributes to neutrophil priming and interleukin-8-directed mucosal recruitment into chronic lesions of patients with Crohn's disease

European Cytokine Network

Volumn 9, Issue 4, 1998, Pages 647-653

  Brandt, Eric ^b   Müller Alouf, Heide ^b   Desreumaux, Pierre ^b   Woerly, Gaëtane ^b   Colombel, Jean Frédéric ^b   Capron, Monique ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b NONE

Author keywords

Chemotaxis; Crohn's disease; GROalpha; Interleukin 8; Neutrophil; Priming

Indexed keywords

CD11B ANTIGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; ALPHA CHEMOKINE; CD15 ANTIGEN; CHEMOTACTIC FACTOR; CXCL1 PROTEIN, HUMAN; GROWTH PROMOTOR; L SELECTIN; SIGNAL PEPTIDE;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; INTESTINE MUCOSA; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; ONCOGENE; SUPERNATANT; BLOOD; CASE CONTROL STUDY; CELL ADHESION; CELL MOTION; DRUG EFFECT; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; MUCOSAL IMMUNITY; NEUTROPHIL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTIGENS, CD15; CASE-CONTROL STUDIES; CELL ADHESION; CELL MOVEMENT; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; CROHN DISEASE; GROWTH SUBSTANCES; HUMANS; IMMUNITY, MUCOSAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; L-SELECTIN; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGE-1 ANTIGEN; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS;

EID: 0032217233     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Butcher E C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. (Review) Cell 67: 1033.
2. Baggiolini M, Dewald B, Moser B. 1994. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. (Review) Adv. Immunol. 55: 97.
3. Buggiolini M, Dewald B, Moser B. 1997. Human chemokines: an update. (Review) Annu. Rev. Immunol. 15: 675.
4. Kitayama J, Carr M W, Roth S J, Buccola J, Springer T A. 1997. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils. J. Immunol. 158: 2340.
5. Campbell J J, Foxman E F, Butcher E C. 1997. Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration. Eur. J. Immunol. 27: 2571.
6. Sahroe I, Williams T J, Hebert C A, Collins P D. 1997. Chemoattractant cross-desensitization of human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J. Immunol. 158: 1361.
7. Ahuja S K, Murphy P M. 1996. The CXC chemokines growth-regulated oncogene (GRO)α, GROβ. GROγ, neutrophil-activating peptide-2 and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A. human interleukin-8 receptor. J. Biol. Chem. 271: 20545.
8. Mitsuyama K, Toyonaga A, Sasaki E, Watanabe K, Tateishi H, Nishiyama T, Saiki T, Ikeda H, Tsuruta O, Tunikawa K. 1994. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 96: 432.
9. Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue J A, Mueller C. 1994. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am. J. Pathol. 144: 997.
10. Grimm M C, Elsbury S K, Pavli P, Doe W F. 1996. Interleukin-8: cells of origin in inflammatory bowel disease. Gut 38: 90.
11. Jones S C, Evans S W, Lobo A J, Ceska M, Axon A T, Whicher J T. 1993. Serum interleukin-8 in inflammatory bowel disease. J. Gastroenterol. Hepatol. 8: 508.
12. Mitsuyama K, Toyonaga A, Tanikawa K. 1996. Role of chemokine GROα in inflammatory bowel disease. Gastroenterology 110: A971 (abstract).
13. Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C, Auer M, Hub E, Rot A. 1997. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91: 385.
14. Yang S K, Kim O H, Lee M H, Song K, Jung H C, Hong W C, Min Y I. 1997. Expression of chemokine genes in the colonic mucosa of patients with ulcerative colitis. Gastroenterology 112: A1126 (abstract).
15. Gower-Rousseau C, Salomez J L, Dupas J L, Marti R, Nuttens M C, Votte A, Lemahieu M, Lemaire B, Colombel J F, Cortot A. 1994. Incidence of inflammatory bowel disease in northern France (1998-1990). Gut 35: 1433.
16. Cassatella M A. 1996. Cytokines produced by polymorphonuclear neutrophils: molecular and biological aspects. Eds Molecular Biology Intelligence Unit. Springer-Verlag, Heidelberg.
17. Falk W, Goodwin R H Jr, Leonard E J. 1980. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. Methods 33: 239.
18. Vainer B. 1997. Role of cell adhesion molecules in inflammatory bowel diseases. (Review) Scand. J. Gastroenterol. 32: 401.
19. Plow E F, Zhang L. 1997. A MAC-1 attack: integrin functions directly challenged in knockout mice. J Clin Invest 99: 1145.
20. Collins C E, Davies C, Macey M G, McCarthy D A, Rampton D S. 1996. Increased expression of circulating leucocyte adhesion molecules CD11b and CD18 in inflammatory bowel disease. Gastroenterology 110: A885 (abstract).
21. Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe A H, von Andrian U H, Arnaout M A, Mayadas TN. 1996. A novel role for the β2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 5: 653.
22. Haraldsen G, Kvale D, Lien B, Farstad I N, Brandtzaeg P. 1996. Cytokine-regulated expression of E-selectin, intracellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human intestinal microvascular endothelial cells. J. Immunol. 156: 2558.
23. Binion D G, Kugathasan S, Wilbur C J, West G A, Miller K A, Ziats N P, Levine A D, Fiocchi C. 1997. Differential production of chemokines MCP-1 and IL-8 between human intestinal microvascular (HIMEC) and large vessel endothelial cells (HUVEC). Gaxtroenterology 112: A936 (abstract).
24. Roberts P J, Pizzey A R, Khwaja A, Carver J E, Mire-Sluis A R, Linch DC. 1993. The effects of interleukin-8 on neutrophil fMetLeuPhe receptors, CD11b expression and metabolic activity, in comparison and combination with other cytokines. Br. J. Haematol. 84: 586.
25. Schaufelberger H D, Uhr M R, McGuckin C, Logan R P, Misiewicz J J, Gordon-Smith E C, Beglinger C. 1994. Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors. Eur. J. Clin. Invest. 24: 656.
26. Meenan J, Spaans J, Grool T, Lammers K, Tytgat G, van Deventer S J H. 1996. Erythrocyte bound chemokine levels are raised in IBD. Gastroenterology 110: A965 (abstract).
27. Holtkamp W, Stollberg T, Reis H E. 1995. Serum interleukin-6 is related to disease activity but not specificity in inflammatory bowel disease. J. Clin. Gastroenterol. 20: 123.
28. Marinaro M, Boyaka P N, Finkelman F D, Kiyono H, Jackson R J, Jirillo E, McGhee J R. 1997. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J. Exp. Med. 185: 415.
29. Harada A, Mukaida N, Matsushima K. 1996. Interleukin-8 as a novel target for intervention therapy in acute inflammatory bowel diseases. (Review) Mol. Med. Today 2: 482.
30. Murthy S, Flanigan A. 1997. Recent developments in inflammatory bowel disease therapy. Exp. Opin. Ther. Patents 7: 695.
31. Baggiolini M, Moser B. 1997. Blocking chemokine receptors. (Review) J. Exp. Med. 186: 1189.